2 Insulet Corp. Analyst Ratings, Earnings, Dividends and Insider Trades | $PODD | NASDAQ:PODD | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact Insulet Corp. Company Profile (NASDAQ:PODD) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for Insulet Corp. (NASDAQ:PODD) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 2 Sell Rating(s), 6 Hold Rating(s), 7 Buy Rating(s)Consensus Rating:Hold (Score: 2.33)Consensus Price Target: $39.02 19.54% downside) Analysts' Ratings History for Insulet Corp. (NASDAQ:PODD) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare3/4/2014ZacksUpgradeUnderperform -> Neutral$48.30View 2/21/2014Feltl & Co.DowngradeHold -> Sell$33.00View 1/24/2014Canaccord GenuityBoost Price TargetBuy$45.00 -> $53.00View 1/13/2014ZacksDowngradeNeutral -> Underperform$34.40View 1/6/2014CRT CapitalInitiated CoverageBuy$53.00View 11/22/2013Raymond JamesUpgradeMarket Perform -> Outperform$43.00View 11/8/2013Jefferies GroupBoost Price TargetBuy$38.00 -> $46.00View 11/8/2013Canaccord GenuityBoost Price TargetBuy$40.00 -> $45.00View 10/15/2013Benchmark Co.Initiated CoverageBuy$44.00View 10/7/2013Ned Davis ResearchInitiated CoverageNeutralView 9/20/2013JMP SecuritiesDowngradeOutperform -> Market Perform$33.00View 8/9/2013Jefferies GroupBoost Price Target$29.00 -> $38.00View 8/8/2013JMP SecuritiesBoost Price TargetMarket Outperform$27.00 -> $33.00View 8/8/2013Canaccord GenuityBoost Price TargetBuy$37.00 -> $40.00View 7/18/2013Northland Capital PartnersDowngradeMarket Perform -> Under Perform$28.00 -> $28.00View 6/25/2013OppenheimerBoost Price TargetOutperform$28.00 -> $35.00View 6/24/2013Canaccord GenuitySet Price TargetBuy$28.00 -> $37.00View 6/20/2013Feltl & Co.DowngradeBuy -> Hold$28.00 -> $33.00View 6/20/2013Leerink SwannSet Price TargetOutperform$30.00 -> $35.00View 6/7/2013WunderlichDowngradeBuy -> Hold$28.00View 5/8/2013Barrington ResearchDowngradeOutperform -> Market PerformView 5/8/2013Northland SecuritiesDowngradeOutperform -> Market Perform$28.00View 5/8/2013Northland Capital PartnersDowngradeOutperform -> Market Perform$28.00View 5/7/2013Jefferies GroupBoost Price TargetBuy$25.00 -> $29.00View 5/7/2013WunderlichBoost Price TargetBuy$24.00 -> $28.00View 5/2/2013Raymond JamesDowngradeOutperform -> Market Perform$25.00View 4/4/2013OppenheimerBoost Price TargetOutperform$24.00 -> $28.00View 3/27/2013Leerink SwannBoost Price Target$30.00View 2/22/2013Canaccord GenuityLower Price TargetBuy$29.00 -> $28.00View 2/15/2013JPMorgan Chase & Co.Reiterated RatingOverweight$26.00View 2/1/2013CL KingUpgradeSell -> NeutralView 12/21/2012Canaccord GenuityBoost Price TargetBuy$24.50 -> $29.00View 12/17/2012Jefferies GroupBoost Price Target$25.00View 12/17/2012StephensDowngradeOverweight -> Equal Weight$24.00View 12/17/2012Piper JaffrayUpgradeNeutral -> Overweight$21.00 -> $27.00View 11/30/2012Raymond JamesInitiated CoverageOutperform$25.00View 9/7/2012Northland SecuritiesInitiated CoverageOutperform$26.00View 8/29/2012WunderlichBoost Price TargetBuy$22.00 -> $24.00View 8/9/2012Canaccord GenuityReiterated RatingBuy -> Buy$27.00 -> $24.50View 7/12/2012CL KingDowngradeNeutral -> SellView 6/29/2012Canaccord GenuityReiterated RatingBuyView 6/22/2012OppenheimerReiterated RatingOutperform$24.00View 5/10/2012Canaccord GenuityReiterated RatingBuyView 4/18/2012Avondale PartnersInitiated CoverageOutperformView 4/18/2012Rodman & RenshawUpgradeMarket Perform -> OutperformView 3/22/2012Piper JaffrayInitiated CoverageNeutralView (Data available from 3/8/2012 forward) Earnings History for Insulet Corp. (NASDAQ:PODD)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare2/27/2014Q413($0.09)($0.04)$67.94 million$68.53 millionViewN/AView 11/7/2013Q313($0.16)($0.39)$62.01 million$61.10 millionViewN/AView 8/7/2013Q2 2013($0.19)($0.20)$60.47 million$60.09 millionViewN/AView 5/6/2013Q1 2013($0.21)($0.20)$57.26 million$57.40 millionViewN/AView 2/27/2013Q4 2012($0.21)($0.21)$59.12 million$57.80 millionViewN/AView 11/8/2012Q312($0.22)($0.26)$54.93 million$54.80 millionViewN/AView 8/8/2012($0.25)($0.30)ViewN/AView 5/9/2012($0.28)($0.31)ViewN/AView 2/9/2012($0.26)($0.30)ViewN/AView 11/3/2011($0.25)($0.29)ViewN/AView 8/2/2011($0.21)($0.42)ViewN/AView 5/9/2011($0.22)($0.22)ViewN/AView 2/15/2011($0.26)($0.50)ViewN/AView (Data available from 1/1/2011 forward) Dividend History for Insulet Corp. (NASDAQ:PODD)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for Insulet Corp. (NASDAQ:PODD)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare3/6/2014R Anthony DiehlGeneral CounselSell12,458$49.28$613,930.24View 3/6/2014Tracey Haas WielinskiVPSell8,275$49.21$407,212.75View 2/3/2014Charles LiamosDirectorSell11,037$42.93$473,818.41View 2/3/2014Duane DesistoCEOSell20,000$42.95$859,000.00View 2/3/2014Peter DevlinInsiderSell30,000$42.82$1,284,600.00View 1/3/2014Charles LiamosCOOSell86,000$36.02$3,097,720.00View 1/2/2014Duane DesistoCEOSell20,000$36.07$721,400.00View 12/3/2013Charles LiamosCOOSell63,808$36.26$2,313,678.08View 11/18/2013Charles LiamosCOOSell80,000$35.60$2,848,000.00View 9/3/2013Duane DesistoCEOSell20,000$33.38$667,600.00View 8/29/2013Sally CrawfordDirectorSell9,000$33.42$300,780.00View 8/15/2013Regina SommerDirectorSell5,000$33.32$166,600.00View 8/1/2013Duane DesistoCEOSell20,000$31.85$637,000.00View 7/1/2013Duane DesistoCEOSell20,000$31.51$630,200.00View 7/1/2013Peter DevlinInsiderSell30,000$31.48$944,400.00View 6/14/2013Sally CrawfordDirectorSell31,000$30.47$944,570.00View 6/10/2013R Anthony DiehlGeneral CounselSell38,455$30.50$1,172,877.50View 6/3/2013Duane DesistoCEOSell20,000$29.76$595,200.00View 12/3/2012Brian K RobertsCFOSell10,000$21.92$219,200.00View 11/1/2012Brian K RobertsCFOSell10,000$21.49$214,900.00View 9/4/2012Brian K RobertsCFOSell10,000$20.78$207,800.00View 9/4/2012Duane DesistoCEOSell20,000$20.97$419,400.00View 9/4/2012Ruthann DepietroVPSell1,000$20.90$20,900.00View (Data available from 1/1/2013 forward) About Insulet Corp. Insulet Corporation is primarily engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (the OmniPod System). The OmniPod System is an insulin infusion system for people with insulin-dependent diabetes. The OmniPod System features a disposable tubeless OmniPod which is worn on the body for approximately three days at a time and the Company's handheld, wireless Personal Diabetes Manager (PDM). The OmniPod Insulin Management System is designed to provide people with insulin-dependent diabetes with a diabetes management solution which provides lifestyle and other benefits and to expand the use of continuous subcutaneous insulin infusion (CSII) therapy. Headlines: (3/7) Earnings Estimates Moving Higher for Insulet (PODD): Time to Buy? (3/7) Earnings Estimates Moving Higher for Insulet (PODD): Time to Buy? - Tale of the Tape Industry, Sector and Symbol: Sector: Healthcare Industry: Health Care Equipment & Supplies Sub-Industry: Health Care Equipment Exchange: NASDAQ Symbol: PODD CUSIP: 45784P10 Key Metrics: Previous Close: $48.8150 Day Moving Average: $44.4888200 Day Moving Average: $38.3926 P/E Ratio: N/AP/E Growth: N/AMarket Cap: $2.670BCurrent Quarter EPS Consensus Estimate: $-0.08 EPS Additional Links: View PODD on Google FinanceView PODD on Yahoo FinanceView PODD's Company Profile on ReutersSearch for Insulet Corp. on Google Insulet Corp. (NASDAQ:PODD) Chart for Saturday, March, 8, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.